COM:PTCBIO
PTC Therapeutics
- Stock
Last Close
42.89
22/11 21:00
Market Cap
3.53B
Beta: -
Volume Today
548.74K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 5.38M - | 13.44M 149.87% | 17.70M 31.75% | 18.99M 7.29% | 17.28M 9.03% | 18.83M 9.00% | 26.19M 39.09% | ||||
average payables | 2.63M - | 8.03M 205.95% | 9.12M 13.51% | 10.79M 18.32% | 10.64M 1.38% | 8.16M 23.30% | 14.49M 77.57% | 20.85M 43.84% | 25.15M 20.63% | 13.63M 45.79% | |
average receivables | 2.70M - | 7.77M 187.61% | 18.01M 131.82% | 32.66M 81.34% | 54.15M 65.79% | 61.72M 13.98% | 62.73M 1.64% | 90.19M 43.77% | 133.03M 47.50% | 158.22M 18.93% | |
book value per share | 9.46 - | 8.88 6.13% | 3.51 60.43% | 3.99 13.66% | 7.53 88.61% | 10.10 34.08% | 7.30 27.70% | 0.02 99.72% | -4.84 23,811.97% | -0.01 99.77% | |
capex per share | -0.15 - | -0.08 45.26% | -0.05 35.51% | -0.08 51.71% | -0.33 321.31% | -0.77 131.51% | -0.85 9.82% | -1.21 42.84% | -2.13 75.52% | -0.00 99.98% | |
capex to depreciation | -2.09 - | -0.95 54.68% | -0.54 42.92% | -0.18 67.51% | -0.60 239.45% | -1.41 137.19% | -0.66 53.29% | -1.33 101.73% | -1.18 11.06% | -0.12 89.75% | |
capex to operating cash flow | 0.08 - | 0.02 73.14% | 0.02 21.61% | 0.31 1,697.00% | 0.56 82.32% | 0.46 18.01% | 0.29 37.39% | 0.34 17.71% | 0.43 25.91% | 0.18 58.01% | |
capex to revenue | -0.20 - | -0.07 63.58% | -0.02 70.97% | -0.02 25.71% | -0.06 267.74% | -0.15 152.32% | -0.15 0.68% | -0.16 7.77% | -0.22 37.71% | -0.03 86.10% | |
cash per share | 18.40 - | 18.43 0.19% | 11.90 35.46% | 6.91 41.93% | 6.13 11.22% | 18.43 200.55% | 16.71 9.33% | 19.26 15.21% | 7.55 60.79% | 0.01 99.84% | |
days of inventory on hand | 857.59 - | 464.30 45.86% | 580.06 24.93% | 360.28 37.89% | 179.02 50.31% | 178.16 0.48% | 170.43 4.34% | ||||
days payables outstanding | -660.26 - | 1.22K - | 172.88 85.81% | 310.53 79.62% | 359.66 15.82% | 260.05 27.69% | 222.77 14.34% | ||||
days sales outstanding | 70.65 - | 110.14 55.88% | 110.02 0.11% | 75.85 31.06% | 93.63 23.44% | 66.03 29.47% | 67.03 1.51% | 74.85 11.67% | 81.28 8.59% | 62.59 22.99% | |
debt to assets | 0.26 - | 0.52 100.89% | 0.53 1.92% | 0.14 74.02% | 0.19 41.38% | 0.19 1.50% | 0.31 60.23% | 0.41 35.23% | 0.22 46.93% | ||
debt to equity | 0.32 - | 1.16 266.94% | 1.32 13.29% | 0.44 66.89% | 0.53 21.04% | 0.87 65.18% | 411.16 47,034.50% | -2.03 100.49% | -0.51 74.99% | ||
dividend yield | |||||||||||
earnings yield | -0.06 - | -0.16 172.69% | -0.38 144.56% | -0.12 68.41% | -0.08 33.71% | -0.09 11.06% | -0.11 22.19% | -0.19 71.67% | -0.20 9.38% | -0.00 99.85% | |
enterprise value | 1.32B - | 845.17M 35.92% | 237.98M 71.84% | 607.30M 155.19% | 1.52B 150.94% | 2.45B 61.06% | 4.24B 72.80% | 2.46B 41.89% | 3.03B 22.97% | 2.06T 67,946.87% | |
enterprise value over ebitda | -13.27 - | -5.06 61.88% | -1.80 64.36% | -12.42 589.00% | -28.15 126.75% | -21.02 25.35% | -18.62 11.42% | -6.52 64.98% | -8.13 24.78% | -4.69K 57,585.21% | |
ev to operating cash flow | -23.03 - | -6.80 70.48% | -2.30 66.20% | -60.35 2,526.38% | -55.13 8.64% | -24.88 54.87% | -21.85 12.17% | -9.81 55.13% | -8.50 13.35% | -13.02K 153,097.16% | |
ev to sales | 57.44 - | 22.99 59.98% | 2.88 87.48% | 3.12 8.57% | 5.76 84.26% | 8.00 38.90% | 11.14 39.31% | 4.58 58.92% | 4.34 5.22% | 2.20K 50,603.88% | |
free cash flow per share | -1.96 - | -3.78 92.56% | -3.09 18.11% | -0.34 89.14% | -0.93 175.89% | -2.45 164.07% | -3.79 54.72% | -4.78 26.16% | -7.10 48.56% | -0.00 99.96% | |
free cash flow yield | -0.04 - | -0.12 207.68% | -0.28 143.19% | -0.02 92.90% | -0.03 34.09% | -0.05 88.70% | -0.06 21.76% | -0.12 93.31% | -0.19 55.02% | -0.00 99.95% | |
graham net net | 17.40 - | 16.61 4.55% | 8.05 51.56% | 1.82 77.43% | -9.10 601.09% | 1.82 119.97% | -8.49 567.54% | -6.94 18.33% | -19.29 178.05% | -0.02 99.88% | |
graham number | 25.14 - | 31.82 26.57% | 18.16 42.91% | 13.46 25.91% | 21.59 60.39% | 31.16 44.36% | 33.01 5.95% | 1.85 94.40% | 29.13 1,476.58% | 0.05 99.84% | |
income quality | 0.61 - | 0.73 19.41% | 0.73 0.10% | 0.13 82.52% | 0.22 69.42% | 0.39 81.68% | 0.44 12.97% | 0.48 8.31% | 0.64 32.99% | 0.25 60.37% | |
intangibles to total assets | 0 - | 0 | 0 | 0.34 Infinity% | 0.70 106.12% | 0.49 30.24% | 0.36 26.02% | 0.42 15.30% | 0.46 10.96% | 0.24 47.28% | |
interest coverage | -84.25 - | 70.61 183.81% | 15.96 77.40% | 5.32 66.68% | 9.21 73.34% | 15.43 67.50% | -7.06 145.74% | -4.36 38.27% | -4.84 11.07% | 3.40 170.28% | |
interest debt per share | 0.04 - | 2.74 7,237.93% | 3.84 40.07% | 4.95 28.88% | 3.02 39.10% | 5.12 69.77% | 7.22 41.04% | 9.61 33.10% | 11.08 15.24% | 0.00 99.97% | |
inventory turnover | 0.43 - | 0.79 84.71% | 0.63 19.96% | 1.01 61.00% | 2.04 101.25% | 2.05 0.48% | 2.14 4.54% | ||||
invested capital | 0.32 - | 1.16 266.94% | 1.32 13.29% | 0.44 66.89% | 0.53 21.04% | 0.87 65.18% | 411.16 47,034.50% | -2.03 100.49% | -0.51 74.99% | ||
market cap | 1.63B - | 1.09B 33.33% | 371.43M 65.91% | 653.57M 75.96% | 1.60B 144.58% | 2.83B 76.87% | 4.03B 42.53% | 2.81B 30.35% | 2.74B 2.45% | 2.06T 75,233.64% | |
net current asset value | 288.82M - | 286.38M 0.85% | 111.52M 61.06% | 13.85M 87.58% | -447.64M 3,332.74% | -250.17M 44.11% | -494.55M 97.69% | -1.16B 135.21% | -1.36B 16.82% | -1.50B 10.06% | |
net debt to ebitda | 3.17 - | 1.46 53.90% | 1.01 30.87% | 0.95 6.38% | 1.38 45.62% | 3.19 131.64% | -0.93 129.11% | 0.90 197.36% | -0.79 186.93% | 0.41 151.80% | |
net income per share | -2.97 - | -5.07 70.66% | -4.17 17.65% | -2.02 51.70% | -2.75 36.39% | -4.27 55.42% | -6.64 55.27% | -7.43 12.04% | -7.79 4.83% | -0.01 99.89% | |
operating cash flow per share | -1.81 - | -3.70 103.79% | -3.04 17.73% | -0.26 91.56% | -0.59 131.08% | -1.68 182.37% | -2.94 75.40% | -3.57 21.35% | -4.97 39.41% | -0.00 99.96% | |
payables turnover | -0.55 - | 0.30 - | 2.11 604.94% | 1.18 44.33% | 1.01 13.66% | 1.40 38.30% | 1.64 16.74% | ||||
receivables turnover | 5.17 - | 3.31 35.85% | 3.32 0.11% | 4.81 45.06% | 3.90 18.99% | 5.53 41.78% | 5.45 1.49% | 4.88 10.45% | 4.49 7.91% | 5.83 29.86% | |
research and ddevelopement to revenue | 3.48 - | 3.31 4.70% | 1.42 57.07% | 0.60 57.52% | 0.65 7.52% | 0.84 29.09% | 1.25 49.58% | 1.00 19.97% | 0.93 7.13% | 0.71 23.76% | |
return on tangible assets | -0.28 - | -0.46 64.60% | -0.53 13.93% | -0.31 42.11% | -0.38 24.87% | -0.30 20.61% | -0.31 2.60% | -0.46 49.15% | -0.61 31.53% | -0.44 28.28% | |
revenue per share | 0.73 - | 1.09 50.30% | 2.43 122.19% | 4.96 104.22% | 5.68 14.57% | 5.22 8.25% | 5.77 10.58% | 7.64 32.54% | 9.74 27.46% | 0.01 99.87% | |
roe | -0.31 - | -0.57 81.80% | -1.19 108.10% | -0.50 57.51% | -0.37 27.69% | -0.42 15.91% | -0.91 114.76% | -364.33 39,976.38% | 1.61 100.44% | 0.77 52.47% | |
roic | -0.32 - | -0.43 34.43% | -0.51 20.21% | -0.18 64.81% | -0.23 27.29% | -0.22 3.05% | -0.43 91.74% | -0.54 27.46% | -0.86 57.54% | 1.77 306.82% | |
sales general and administrative to revenue | 1.95 - | 2.23 14.38% | 1.17 47.39% | 0.62 46.88% | 0.58 7.03% | ||||||
shareholders equity per share | 9.46 - | 8.88 6.13% | 3.51 60.43% | 3.99 13.66% | 7.53 88.61% | 10.10 34.08% | 7.30 27.70% | 0.02 99.72% | -4.84 23,811.97% | -0.01 99.77% | |
stock based compensation to revenue | 0.84 - | 0.92 9.90% | 0.42 54.20% | 0.16 62.86% | 0.13 20.10% | 0.14 9.27% | 0.18 34.56% | 0.19 4.06% | 0.16 17.85% | 0.11 31.36% | |
tangible asset value | 298.47M - | 298.47M 0% | 119.58M 59.93% | 23.44M 80.40% | -432.64M 1,945.44% | -198.51M 54.12% | -315.69M 59.03% | -805.74M 155.24% | -1.14B 40.90% | -1.28B 12.78% | |
tangible book value per share | 9.46 - | 8.88 6.13% | 3.51 60.43% | 0.60 82.97% | -9.29 1,652.51% | -3.37 63.69% | -4.78 41.77% | -11.43 139.16% | -15.83 38.42% | -0.02 99.89% | |
working capital | 291.10M - | 310.56M 6.69% | 211.66M 31.85% | 167.01M 21.09% | 154.06M 7.76% | 543.43M 252.73% | 954.41M 75.63% | 264.03M 72.34% | 287.55M 8.91% | 615.53M 114.06% |
All numbers in USD (except ratios and percentages)